Imo the study was solid and the results are not their fault but their PR and management of the release was pathetic.
Everyone holding now likely has some variation of belief that more data analysis may give better results. Given the quality and delivery of this latest announcement I think management made that belief very hard to have. If there are positive points that do come out of the data in future I also find myself of the view that they will be incapable of effectively conveying this to the market.
Ann: Results of LCT Parkinsons trial require further analysis, page-107
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
